INVESTOR RIGHTS AGREEMENT among SEATTLE GENETICS, INC and THE INVESTORS NAMED HEREIN Dated as of July 8, 2003Investor Rights Agreement • November 7th, 2008 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Delaware
INVESTOR RIGHTS AGREEMENT dated as of July 8, 2003, among SEATTLE GENETICS, INC., a Delaware corporation (the “Company”), and the INVESTORS of the Company listed on Schedule I hereto, and their permitted assigns (collectively, the “Investors”).
SECOND AMENDMENT TO LEASELease • November 7th, 2008 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances)
This SECOND AMENDMENT TO LEASE (this “Amendment”) is entered into effective as of July 1, 2008 (the “Effective Date”) between B&N 141-302, LLC, a Washington limited liability company (“Landlord”) and SEATTLE GENETICS, INC., a Delaware corporation (“Tenant”).
ContractCollaboration Agreement • November 7th, 2008 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
